The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...

Risk of long-term mortality is independently associated with eosinophil counts 5 to 7 days after onset in patients with acute myocardial infarction.

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.